Annemiek M E Walenkamp Selected Research

Annemiek M E Walenkamp Research Topics

Disease

31	Neoplasms (Cancer) 12/2022 - 01/2009
10	Glioblastoma (Glioblastoma Multiforme) 12/2022 - 01/2014
6	Neoplasm Metastasis (Metastasis) 06/2022 - 04/2009
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2021 - 07/2014
4	Breast Neoplasms (Breast Cancer) 08/2021 - 12/2011
3	Glioma (Gliomas) 01/2022 - 04/2013
3	Testicular Neoplasms (Testicular Cancer) 11/2021 - 01/2016
2	Hemangioblastoma 10/2016 - 08/2012
2	Residual Neoplasm 01/2015 - 08/2012
2	Prostatic Neoplasms (Prostate Cancer) 10/2014 - 08/2012
2	Infections 08/2014 - 04/2009
2	Leukemia 08/2012 - 01/2010
2	Carcinoma (Carcinomatosis) 08/2012 - 04/2009
1	Hypogonadism (Hypergonadotropic Hypogonadism) 11/2021
1	Cognitive Dysfunction 11/2021
1	Overweight 08/2021
1	Adenocarcinoma 05/2021
1	Carcinogenesis 05/2021
1	Neuroendocrine Carcinoma 05/2021
1	Vision Disorders (Hemeralopia) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2020
1	Melanoma (Melanoma, Malignant) 07/2020
1	Pheochromocytoma 07/2020
1	Male Breast Neoplasms (Male Breast Cancer) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Pellagra 01/2016
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2016

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 07/2020 - 12/2011
4	Pharmaceutical PreparationsIBA 01/2021 - 12/2011
4	Serotonin (5 Hydroxytryptamine)IBA 12/2020 - 10/2014
4	Bevacizumab (Avastin)FDA Link 07/2015 - 07/2014
4	ChemokinesIBA 01/2015 - 01/2004
3	Dihydroxyphenylalanine (Dopa)IBA 06/2022 - 08/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2014
3	Dopamine (Intropin)FDA LinkGeneric 09/2021 - 10/2014
3	Lomustine (CCNU)FDA Link 01/2021 - 08/2014
3	LigandsIBA 01/2020 - 01/2015
3	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2015 - 12/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 06/2013
3	plerixafor FDA Link 10/2014 - 08/2012
2	epidermal growth factor receptor VIIIIBA 12/2022 - 01/2020
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 06/2022 - 03/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2014
2	Biological ProductsIBA 05/2021 - 08/2019
2	fluorodopa F 18IBA 03/2021 - 08/2018
2	depatuxizumab mafodotinIBA 01/2021 - 01/2020
2	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 01/2016
2	Dopamine Receptors (Dopamine Receptor)IBA 07/2020 - 10/2014
2	Messenger RNA (mRNA)IBA 07/2020 - 01/2020
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 08/2014
2	CXC ChemokinesIBA 01/2020 - 01/2017
2	89Zr-bevacizumabIBA 01/2016 - 07/2014
2	fresolimumabIBA 09/2015 - 12/2011
2	Protein Isoforms (Isoforms)IBA 09/2015 - 12/2011
2	Monoclonal AntibodiesIBA 09/2015 - 06/2013
2	Chemokine ReceptorsIBA 01/2015 - 04/2009
1	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2022
1	Radioisotopes (Radionuclides)IBA 06/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2022
1	Peptide Receptors (Peptide Receptor)IBA 06/2022
1	selinexorIBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	Testosterone (Sustanon)FDA Link 11/2021
1	Advanced Glycation End ProductsIBA 11/2021
1	Carboxy-LyasesIBA 09/2021
1	Amino Acids FDA Link 09/2021
1	Alanine (L-Alanine)FDA Link 09/2021
1	EnzymesIBA 09/2021
1	Ga(III)-DOTATOCIBA 03/2021
1	Tumor Biomarkers (Tumor Markers)IBA 03/2021
1	NucleotidesIBA 01/2020
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2020
1	RGB 286638IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	EpitopesIBA 01/2020
1	indoleIBA 11/2019
1	ErbB Receptors (EGF Receptor)IBA 08/2019
1	AminesIBA 08/2019
1	CatecholaminesIBA 08/2019
1	Levodopa (L Dopa)FDA LinkGeneric 08/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2017
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2017
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2016
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2016
1	Tryptophan (L-Tryptophan)FDA Link 01/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016
1	ParaffinIBA 01/2015
1	N 30IBA 01/2015

Therapy/Procedure

10	Therapeutics 06/2022 - 08/2012
5	Drug Therapy (Chemotherapy) 11/2020 - 08/2012
4	Radiotherapy 01/2017 - 01/2009
3	Aftercare (After-Treatment) 11/2021 - 10/2017
3	Chemoradiotherapy 12/2018 - 08/2014
1	Immunotherapy 01/2020
1	Adjuvant Chemotherapy 10/2017
1	Combination Drug Therapy (Combination Chemotherapy) 01/2016
1	Neoadjuvant Therapy 01/2015